Quick Answer
LIGAND PHARMACEUTICALS INC reported Stockholders Equity of $1.02 billion for fiscal year 2025.
LIGAND PHARMACEUTICALS INC Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $1.02B | +22.5% |
| 2024 | $830.44M | +18.5% |
| 2023 | $700.91M | +17.3% |
| 2022 | $597.49M | -27.2% |
| 2021 | $821.16M | +15.7% |
| 2020 | $709.52M | -7.5% |
| 2019 | $767.23M | +36.8% |
| 2018 | $560.91M | +40.3% |
| 2017 | $399.79M | +17.1% |
| 2016 | $341.29M | +43.8% |
| 2015 | $237.28M | +801.6% |
| 2014 | $26.32M | -47.0% |
| 2013 | $49.61M | +87.3% |
| 2012 | $26.48M | +223.6% |
| 2011 | $8.19M | +268.8% |
| 2010 | -$4.85M | -229.5% |
| 2009 | $3.74M | +136.1% |
| 2008 | -$10.37M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $950.17M | +13.0% | +14.9% |
| June 30, 2025 | $827.31M | +6.7% | +4.0% |
| March 31, 2025 | $795.59M | -1.4% | -4.2% |
| December 31, 2024 | $830.44M | +18.5% | -1.3% |
| September 30, 2024 | $841.18M | +25.9% | +8.5% |
| June 30, 2024 | $775.20M | +16.6% | -3.9% |
| March 31, 2024 | $806.52M | +24.8% | +15.1% |
| December 31, 2023 | $700.91M | +17.3% | +4.9% |
- LIGAND PHARMACEUTICALS INC showed an increase of +22.5% in Stockholders Equity compared to the prior fiscal year.
- Over the 2008–2025 period, LIGAND PHARMACEUTICALS INC’s stockholders equity has grown by 9913.9% (from -$10.37 million to $1.02 billion).
- The most recent figure is from LIGAND PHARMACEUTICALS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: